Beam Therapeutics IncBEAM
Price$24.39Intrinsic value$43.0877% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $43.08median of 2 methodsbased on filings through 30 Jun 2026
Market Price $24.39Price as of 1 Oct 2026
Margin of Safety +76.7%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 13.0%
Volatility vs market (adjusted beta)1.79

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetBeam Therapeutics IncBEAMHealth Care
Valuation
P/E—
P/S16.3×
P/B2.5×
EV / Revenue15.6×
EV / EBITDA-7.0×
Profitability
Gross margin100.0%
Operating margin-274.6%
Net margin-55.5%
FCF margin-238.9%
Returns
ROE-8.1%
ROA-6.2%
ROIC—
Growth
Revenue growth (YoY)145.7%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.09×
Current ratio14.57×
Altman Z-Score3.3
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.